the current state of the art in all and how novel agents are impacting the field
Published 1 year ago • 34 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
1:19
the current state-of-the-art in pv and future outlooks
-
2:16
the current state-of-the-art in mf and pv therapy and future outlooks
-
7:10
the current state of the art in r/r multiple myeloma: a european perspective
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:19
the current state of the art in frontline myeloma treatment: a european perspective
-
21:38
drawing the line: the rationale behind blood tube collection order
-
41:51
varian - head and neck treatment planning (2022).
-
1:29:46
htic 2022: computational oncology and personalized medicine | tuesday, october 11, 2022, 11:00 a.m.
-
1:58
mrd as a surrogate endpoint for aml therapy
-
1:08
the progress of the ebmt & key ongoing projects
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
2:50
state of the art in car-t
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
4:27
insights into a novel murine model being used to investigate the pathophysiology of icans
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
2:41
an overview of the latest advances in hematology
-
1:24
detection of circulating ttr aggregates: a potential novel biomarker for attr amyloidosis
-
1:55
mesenchymal stromal cells in 2020